Acquiring Company
Novo Holdings
Acquired Company
Catalent Pharma Solutions
Hellerup
SomersetBiotechnologyHealth CareVenture CapitalLife ScienceManufacturingBiotechnologyHealthcareHealth CareDescription
Novo Holdings, a holding and investment company, has entered into a merger agreement to acquire Catalent, Inc. in an all-cash transaction valued at $16.5 billion. This acquisition will provide Catalent with significant resources to accelerate investment in the business and enhance key offerings, while also aligning with Novo Holdings' mandate to invest in high-quality life sciences companies for the benefit of the Novo Nordisk Foundation’s mission and philanthropic causes.
Quick answer
Novo Holdings is acquiring Catalent Pharma Solutions, announced February 5, 2024. Novo Holdings is based in Hellerup, Hovedstaden, Denmark.
- How much did Novo Holdings pay for Catalent Pharma Solutions?
- The deal value was not disclosed.
- What does Novo Holdings do?
- Novo Holdings A/S is a leading international healthcare and life sciences investor wholly owned by the Novo Nordisk Foundation.
- Where are Novo Holdings and Catalent Pharma Solutions based?
- Novo Holdings is based in Hellerup, Hovedstaden, Denmark. Catalent Pharma Solutions is based in Somerset, New Jersey, United States.
- Who are the decision-makers at Novo Holdings?
- Fundz holds 1 contact at Novo Holdings. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Venture Capital and Life Science
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Bristol Myers Squibb completes acquisition of Karuna Therapeutics, Inc. to strengthen its neuroscience portfolio (March 18, 2024)
- Branded Legacy, Inc. signs letter of intent to purchase Sycamore BioPharma, LLC, to strengthen its position in the BioTech industry (March 1, 2024)
- XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right (February 16, 2024)
- Avista Capital Partners Acquires Terrats Medical from Miura Partners (February 16, 2024)
- Novartis completes acquisition of IFM Due to develop first-in-class STING antagonist program targeting innate immune system (March 13, 2024)
- Bruker Corporation completes acquisition of Chemspeed Technologies AG to expand vendor-agnostic scientific software and laboratory automation (March 7, 2024)
Who to call at Novo Holdings, and when
When Novo Holdings changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Novo Holdings raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Novo Holdings, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Novo Holdings. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Novo Holdings makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Catalent Pharma Solutions?
Catalent Pharma Solutions was acquired by Novo Holdings, based in Hellerup. The deal was reported on February 5, 2024. Novo Holdings A/S is a leading international healthcare and life sciences investor wholly owned by the Novo Nordisk Foundation. Novo Holdings is privately held and operates in Biotechnology.
When did Novo Holdings acquire Catalent Pharma Solutions?
Novo Holdings's acquisition of Catalent Pharma Solutions was reported on February 5, 2024. Novo Holdings, a holding and investment company, has entered into a merger agreement to acquire Catalent, Inc. in an all-cash transaction valued at $16.5 billion. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Catalent Pharma Solutions do?
Catalent Pharma Solutions offers advanced technologies, drug delivery systems, and development solutions. They are known for their expertise in drug manufacturing and solutions that help bring medicines to market efficiently. It is privately held, operating in Manufacturing, and is based in Somerset.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.